Search results for "Pulmonary Disease"

showing 10 items of 360 documents

Expertise préalable à la création d’un tableau de maladie professionnelle ou à l’élaboration de recommandations aux comités régionaux dereconnaissanc…

2022

Le plan d’actions sur les produits phytopharmaceutiques publié en avril 2018 vise notamment, sur la base des recommandations formulées par l’Inspection générale des affaires sociales, l’Inspection générale des finances et le Conseil général de l’alimentation, de l’agriculture etdes espaces ruraux dans leur rapport conjoint de janvier 2018, à améliorer la prise en charge des maladies professionnelles liées aux pesticides.Dans ce cadre, les pouvoirs publics ont, par courrier en date du 24 avril 2018, saisi l’Institut national de la santé et de la recherche médicale (Inserm) afin d’actualiser l’expertise collective « Pesticides : effets sur la santé » parue en 2013. Cette expertise synthétise …

medical diagnosis[SDV]Life Sciences [q-bio]causal relationshipreconnaissanceOccupational diseaseoccupational exposurepesticidesMaladie professionnellechronic obstructive pulmonary diseasecompensationexposition professionnelle[SDV] Life Sciences [q-bio]diagnostic médical[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBronchopneumopathie chronique obstructive[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologierelation causale
researchProduct

Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease

2021

Noninvasive ventilation (NIV) represents the standard of care for respiratory support of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) developing acute hypercapnic respiratory failure (AHRF) [1]. NIV has been shown to reduce patient’s work of breathing and mortality and be feasibly implemented in various hospital location facilities at different timing, based on the severity of AHRF [2] and it is also widely used in clinical practice by physicians [3]. However, clinicians’ knowledge, experience and expertise in the management of NIV are crucial for its success in order to overcome common problems that may lower its effectiveness such as patients’ discomf…

medicine.medical_specialtyAcute hypercapnic respiratory failureacute respiratory failurehigh-flow nasal cannulabusiness.industryHealth PolicyPulmonary diseasenoninvasive ventilationPulmonary Disease Chronic ObstructiveCOPD exacerbationCopd exacerbationInternal medicineCardiologymedicineHumansNoninvasive ventilationAcute respiratory failureHigh flowbusinessNIV HFNTacute hypercapnic respiratory failure
researchProduct

Cardiovascular and Other Health Benefits of Sauna Bathing:A Review of the Evidence

2018

Sauna bathing, an activity that has been a tradition in Finland for thousands of years and mainly used for the purposes of pleasure and relaxation, is becoming increasingly popular in many other populations. Emerging evidence suggests that beyond its use for pleasure, sauna bathing may be linked to several health benefits, which include reduction in the risk of vascular diseases such as high blood pressure, cardiovascular disease, and neurocognitive diseases; nonvascular conditions such as pulmonary diseases; mortality; as well as amelioration of conditions such as arthritis, headache, and flu. The beneficial effects of sauna bathing on these outcomes have been linked to its effect on circu…

medicine.medical_specialtyBathingDiseaselaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineCardiovascular Physiological Phenomena030212 general & internal medicineIntensive care medicinepulmonary diseasebusiness.industryFinnish sauna bathingblood pressureCardiorespiratory fitnessvascular diseaseGeneral Medicinearchitecture.stylemortalityBlood pressurearchitectureFinnish SaunaObservational studybusinessAlzheimer’s disease030217 neurology & neurosurgerydementia
researchProduct

High flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time?

2021

medicine.medical_specialtyCOPD2019-20 coronavirus outbreakNoninvasive VentilationExacerbationCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Oxygen Inhalation TherapyPulmonary diseaseGeneral Medicinemedicine.diseasePulmonary Disease Chronic ObstructiveEmergency MedicineCOPDHumansMedicineNoninvasive ventilationbusinessIntensive care medicineHigh flowThe American Journal of Emergency Medicine
researchProduct

Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study

2016

Introduction: In Central and Eastern Europe (CEE) the burden of chronic obstructive pulmonary disease (COPD) is high. It remains unknown whether patients are treated in line with GOLD recommendations or according to their phenotypes. Our aim was to analyze the treatment patterns of COPD in CEE. Methods: In the frame of the POPE study (ClinicalTrials.gov - NCT02119494) data including pharmacotherapy were collected in patients with stable COPD across 11 CEE countries. Results: 3366 patients (66±9 yrs, 70% male, FEV 1 53±18%) participated in the study. In all GOLD categories, the most widely used medications were long-acting beta-2 agonists (LABA), followed by long-acting antimuscarinic agents…

medicine.medical_specialtyCOPDbiologyExacerbationbusiness.industryPulmonary diseaseInhaled corticosteroidsOverlap syndromeLamabiology.organism_classificationmedicine.disease3. Good health03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemInternal medicinePhysical therapyMedicineIn patient030212 general & internal medicinebusinesshormones hormone substitutes and hormone antagonists1.12 Clinical Problems - COPD
researchProduct

How Can We Assess the Perception of Induced Dyspnea in Chronic Obstructive Pulmonary Disease?

2004

Objective TO evaluate various methods for studying the perception of dyspnea in chronic obstructive pulmonary disease (COPD) using a new parameter, the change in Borg scale rating, and others already in use: the linear regression slope and the application of Stevens' law to the response-perception curve-ie change in forced expiratory volume in 1 second (ΔFEV 1 )-change in dyspnea (Adyspnea). Patients and method A bronchial challenge test was performed on 70 patients with stable COPD and no contraindications for performing the test (European Respiratory Society criteria), during which dyspnea was measured (Borg scale) after each nebulization. Perception was analyzed using: a ) the linear reg…

medicine.medical_specialtyCOPDgenetic structuresInhalationmedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectPulmonary diseaseBronchial provocation testsGeneral Medicinemedicine.diseaserespiratory tract diseasesPerceptionSeverity of illnessPhysical therapyMedicineBronchial challenge testsense organsbusinessmedia_commonArchivos de Bronconeumología ((English Edition))
researchProduct

Impact of domestic mould exposure on Aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease

2021

International audience; Patients with chronic obstructive pulmonary disease (COPD) are frequently colonised or sensitised by Aspergillus, but clinical significance remains unclear. Furthermore, little is known on the impact of indoor mould exposure during COPD. In this study, we assessed the relationship between domestic mould exposure, Aspergillus biomarkers and COPD severity during acute exacerbation and at stable state. Aspergillus section Fumigati culture in sputum and anti-Aspergillus antibodies detection (IgG and precipitins) were followed up in COPD patients that were prospectively recruited during exacerbation (n = 62), and underwent a visit at stable state after 18 months (n = 33).…

medicine.medical_specialtyExacerbationMESH: Pulmonary Disease Chronic Obstructive010501 environmental sciencesEnvironmentMESH: Forced Expiratory VolumeAspergillosis01 natural sciencesBiochemistryGastroenterologyPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineanti-Aspergillus antibodiesForced Expiratory VolumeInternal medicinemedicineAspergillosisHumansCOPDClinical significanceMESH: Lung030212 general & internal medicineMESH: AspergillosisLungLung function0105 earth and related environmental sciencesGeneral Environmental Science[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthCOPDAspergillusMESH: Humansbiologybusiness.industryFungimedicine.diseasebiology.organism_classificationrespiratory tract diseasesAspergillusMESH: Aspergillusbiology.proteinMESH: BiomarkersSputummedicine.symptomAntibodybusinessBiomarkers
researchProduct

Pharmacological Management of Elderly Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?

2016

Asthma and chronic obstructive pulmonary disease (COPD) are two distinct diseases that share a condition of chronic inflammation of the airways and bronchial obstruction. In clinical settings, it is not rare to come across patients who present with clinical and functional features of both diseases, posing a diagnostic dilemma. The overlap condition has been termed asthma–COPD overlap syndrome (ACOS), and mainly occurs in individuals with long-standing asthma, especially if they are also current or former smokers. Patients with ACOS have poorer health-related quality of life and a higher exacerbation rate than subjects with asthma or COPD alone. Whether ACOS is a distinct nosological entity …

medicine.medical_specialtyExacerbationPopulationSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinePharmacotherapyAdrenal Cortex HormonesAdministration InhalationPrevalencemedicineHumansPharmacology (medical)030212 general & internal medicineIntensive care medicineeducationAgedAsthmaCOPDeducation.field_of_studyLungbusiness.industryOverlap syndromemedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesmedicine.anatomical_structure030228 respiratory systemQuality of LifePhysical therapyDrug Therapy CombinationSalmeterolGeriatrics and Gerontologybusinessmedicine.drugDrugs & Aging
researchProduct

Inspiratory muscle training combined with pursed lip technique in women with chronic osbtructive pulmonary disease: a case study.

2020

Objective. To improve pulmonary function, exercise capacity and quality of life of two women with Chronic Obstructive Pulmonary Disease (COPD). Material and Methods. Study of two clinical cases, both women. An intervention of 8 weeks was performed, in which the patients performed 3 weekly sessions, of which 1 was performed with supervision of the physiotherapist and 2 sessions were performed at home. The treatment sessions consisted of inspiratory muscle training with an inspiratory threshold and controlled breathing exercises with the pursed lip technique. Results. Quality of life of both women improved at the end of the study. In the woman with severe COPD, Maximal Inspiratory Pressure (M…

medicine.medical_specialtyFisioteràpiaAerospace EngineeringPulmonary diseaseSevere copdchronic obstructive pulmonary diseasePulmonary function testinglcsh:GV557-1198.995Quality of lifeMedicinelcsh:Sports medicinepursed liplcsh:SportsCOPDinspiratory muscle trainingControlled breathingbusiness.industryInspiratory muscle trainingExercise capacitymedicine.diseaserespiratory tract diseasesrespiratory physiotherapyPhysical therapylcsh:RC1200-1245businessPulmons Malalties
researchProduct

Patterns and Predictors of Recovery from Poor Health Status Measured with the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test in Patient…

2019

Recent recommendations for chronic obstructive pulmonary disease (COPD) suggest that evaluation and management should focus on patient health status. Despite the frequency of poor health status and its negative impact on patients with COPD, little is known about how poor or non-poor health status persists and/or remits over time or what factors might predict recovery from a poor health status. The aim was to determine the likelihood of transitioning between poor and non-poor health status in patients with stable COPD followed for 2 years and to investigate factors that might predict recovery from poor health status. We prospectively included 137 patients with stable COPD (mean age, 66.9 yea…

medicine.medical_specialtyLongitudinal studyPulmonary diseaselcsh:Medicinehealth statusnon-smokerArticle03 medical and health sciencesrecovery0302 clinical medicineInternal medicinemedicineCOPDIn patient030212 general & internal medicineGeneralized estimating equationLungs -- DiseasesCOPDhandgrip strengthbusiness.industrylcsh:RPulmons -- MalaltiesCATGeneral MedicineOdds ratiomedicine.diseaseConfidence interval030228 respiratory systemCopd assessment testbusinesstransitionsJournal of Clinical Medicine
researchProduct